Clinical Trials Logo

Inverse Psoriasis clinical trials

View clinical trials related to Inverse Psoriasis.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT02695940 Completed - Inverse Psoriasis Clinical Trials

Trial Twice Daily Application of LEO 124249 Ointment 30 mg/g in Treatment of Mild to Moderate Inverse Psoriasis

Start date: March 2016
Phase: Phase 2
Study type: Interventional

This is a phase 2a trial testing twice daily administration of LEO 124249 ointment 30 mg/g in the treatment of mild to moderate inverse psoriasis. Patients will be treated for 6 weeks, and the efficacy and safety will be compared with the treatment of LEO 124249 ointment vehicle.